PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 87 filers reported holding PMV PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $504,616 | -0.9% | 82,185 | +1.1% | 0.00% | – |
| Q2 2023 | $509,063 | +30.8% | 81,320 | -0.3% | 0.00% | – |
| Q1 2023 | $389,256 | -44.3% | 81,605 | +1.6% | 0.00% | – |
| Q4 2022 | $699,000 | -26.9% | 80,325 | -0.0% | 0.00% | – |
| Q3 2022 | $956,000 | -18.1% | 80,330 | -1.9% | 0.00% | – |
| Q2 2022 | $1,167,000 | -5.9% | 81,851 | +37.4% | 0.00% | – |
| Q1 2022 | $1,240,000 | +4.0% | 59,593 | +15.5% | 0.00% | – |
| Q4 2021 | $1,192,000 | +24.2% | 51,587 | +60.1% | 0.00% | – |
| Q3 2021 | $960,000 | -15.7% | 32,216 | -8.5% | 0.00% | – |
| Q2 2021 | $1,139,000 | +99.8% | 35,206 | +103.3% | 0.00% | – |
| Q1 2021 | $570,000 | +156.8% | 17,319 | +379.4% | 0.00% | – |
| Q4 2020 | $222,000 | – | 3,613 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 4,179,416 | $257,076,000 | 54.42% |
| INTERWEST VENTURE MANAGEMENT CO | 6,469,911 | $397,964,000 | 49.71% |
| Octagon Capital Advisors LP | 250,000 | $15,378,000 | 5.33% |
| Boxer Capital, LLC | 2,268,236 | $139,519,000 | 4.48% |
| COMMODORE CAPITAL LP | 125,000 | $7,689,000 | 4.18% |
| Orbimed Advisors | 7,330,423 | $450,894,000 | 3.95% |
| Asymmetry Capital Management, L.P. | 96,595 | $5,942,000 | 2.71% |
| Avoro Capital Advisors LLC | 2,350,267 | $130,536,000 | 2.25% |
| RA Capital Management | 1,710,265 | $105,198,000 | 1.47% |
| HighVista Strategies LLC | 22,654 | $1,393,000 | 0.89% |